A rare genetic disease known since ancient times, hemophilia affects nearly 8000 French people today. In the 1950s, Dr. Emile Remigy, pushed back the limits of their life expectancy. He developed a treatment, a frozen cryoprecipitate which, once injected into the patient, made up for their lack of coagulant proteins. The industrialization of this product was made possible in France thanks to blood donations, a practice encouraged since 1949, when the National Blood Transfusion Center was created in Paris, which advocates volunteerism, anonymity and non-profit. But what if the State was capable of putting its population at risk for the sake of financial gain? Learn more about your ad choices. Visit megaphone.fm/adchoices